Score
2
1990
pubmed
[The effect of a synthetic thymus peptide (thymogen) on the immune system in candidiasis under immunodepression].
Khmel'nitskiĭ. O K OK; Iakovlev. G M GM; Belianin. V L VL; Khavinson. V Kh VKh; Morozov. V G VG; Deĭgin. V I VI
Key Findings
- Thymogen injections reduced the severity of candidiasis in immunodepressed subjects
- The peptide appears to activate the immune system, including the thymus
- Improved outcomes suggest thymogen may aid in fighting fungal infections
Practical Outcomes
- Thymogen shows promise as an immune‑boosting agent against fungal infections, but the evidence is limited to experimental models. Biohackers should treat this as early‑stage research and wait for human safety and dosage data before considering it in any protocol.
Summary
In a lab study where animals with a weakened immune system got a fungal infection, giving them the synthetic peptide thymogen made the infection less severe, hinting that the peptide can boost the immune system and help clear the fungus.
Abstract
Experimental candidiasis developing against the background of the secondary immunodeficiency is described. After thymogen injections the course of candidiasis proceeds less severely, this suggesting that thymogen activates the immunocompetent system, including thymus, favouring the disappearance of the fungal infection.
Study Information
Provider
pubmed
Year
1990